SUNNYVALE, Calif., Feb. 8 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune mediated diseases and cancer, today announced that it will report financial result
http://digg.com/u1Mmrw
No comments:
Post a Comment